Table 1 Characteristics of all the patients and SUVmax of the parietal bones and jawbone lesion
No. | Sex | Age (years) | Primary cancer disease | ARD | MRONJ stage | Jawbone | SUVmax of the parietal bones | SUVmax of the jawbone lesion | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 h | 3 h | 3 h − 2 h | 2 h | 3 h | 3 h − 2 h | |||||||
1 | M | 75 | Multiple myeloma | ZA-Dmab | 2 | Maxilla and mandible | 1.58 | 1.54 | -0.04 | 17.21 | 17.32 | 0.11 |
2 | F | 65 | Breast cancer | ZA-Dmab | 1 | Mandible | 2.91 | 3.32 | 0.41 | 9.35 | 11.06 | 1.71 |
3 | F | 73 | Breast cancer | ZA-Dmab | 3 | Mandible | 2.49 | 2.51 | 0.01 | 7.21 | 6.65 | -0.56 |
4 | M | 78 | Prostate cancer | ZA | Healed | Mandible | 1.11 | 0.86 | -0.25 | 5.56 | 5.13 | -0.43 |
5 | M | 78 | Prostate cancer | Dmab | 0 | Mandible | 1.46 | 1.42 | -0.04 | 10.34 | 9.83 | -0.51 |
6 | M | 80 | Prostate cancer | ZA-Dmab | Healed | Maxilla | 1.85 | 1.80 | -0.04 | 5.64 | 6.82 | 1.18 |
7 | F | 55 | Breast cancer | ZA-Dmab | 2 | Maxilla | 1.64 | 1.67 | 0.03 | 11.38 | 11.81 | 0.43 |
8 | F | 57 | Breast cancer | Dmab | 2 | Mandible | 1.34 | 1.37 | 0.03 | 6.66 | 7.42 | 0.76 |
9 | F | 73 | Breast cancer | Dmab | 3 | Maxilla | 2.86 | 2.75 | -0.11 | 10.46 | 12.12 | 1.66 |
10 | F | 73 | Breast cancer | Dmab | 2 | Mandible | 1.95 | 2.18 | 0.23 | 8.43 | 8.98 | 0.55 |
11 | F | 70 | Lymphoma | Alendronate | 2 | Mandible | 3.06 | 2.95 | -0.12 | 9.27 | 9.42 | 0.15 |
12 | F | 73 | Breast cancer | Dmab | 2 | Mandible | 2.91 | 2.61 | -0.30 | 16.93 | 18.13 | 1.20 |
13 | F | 70 | Breast cancer | Dmab | 1 | Mandible | 1.61 | 1.56 | -0.05 | 4.88 | 4.64 | -0.24 |
14 | F | 78 | Breast cancer | Dmab | 3 | Maxilla | 3.27 | 3.30 | 0.03 | 10.50 | 10.17 | -0.33 |
15 | M | 61 | Prostate cancer | Dmab | 0 | Mandible | 1.61 | 1.60 | -0.01 | 16.45 | 16.88 | 0.43 |
16 | F | 60 | Breast cancer | Dmab | 2 | Mandible | 1.96 | 1.78 | -0.18 | 5.11 | 5.17 | 0.06 |
17 | F | 71 | Breast cancer | Dmab | 2 | Maxilla | 1.40 | 1.45 | 0.04 | 10.70 | 11.05 | 0.35 |
18 | F | 52 | Breast cancer | Dmab | 0 | Maxilla | 1.52 | 1.40 | -0.12 | 5.05 | 5.38 | 0.33 |
19 | M | 73 | Multiple myeloma | Dmab | 1 | Mandible | 1.60 | 1.66 | 0.06 | 14.53 | 14.64 | 0.11 |
20 | F | 81 | Multiple myeloma | Dmab | 0 | Mandible | 2.59 | 2.67 | 0.08 | 6.54 | 6.53 | -0.01 |
21 | M | 72 | Lung cancer | Dmab | 2 | Mandible | 1.47 | 1.30 | -0.17 | 5.10 | 5.54 | 0.44 |
22 | F | 66 | Prostate cancer | Dmab | 2 | Mandible | 2.02 | 2.09 | 0.07 | 5.02 | 5.09 | 0.07 |
23 | M | 75 | Thyroid cancer | ZA | 2 | Mandible | 2.18 | 1.89 | -0.29 | 11.69 | 12.93 | 1.24 |
24 | F | 56 | Breast cancer | Dmab | 2 | Maxilla | 1.75 | 1.82 | 0.07 | 9.22 | 9.36 | 0.14 |
25 | F | 69 | Breast cancer | ZA-Dmab | Healed | Maxilla | 2.39 | 2.44 | 0.05 | 6.18 | 6.94 | 0.76 |
26 | F | 59 | Breast cancer | ZA-Dmab | 2 | Mandible | 1.64 | 1.54 | -0.10 | 6.48 | 6.10 | -0.38 |
27 | M | 73 | Multiple myeloma | Dmab | 2 | Mandible | 1.40 | 1.37 | -0.02 | 11.39 | 12.27 | 0.88 |
28 | F | 51 | Breast cancer | ZA-Dmab | 2 | Mandible | 2.15 | 2.00 | -0.16 | 6.20 | 6.23 | 0.03 |
29 | F | 70 | Breast cancer | Dmab | 3 | Maxilla | 2.35 | 2.28 | -0.07 | 11.11 | 11.75 | 0.64 |
30 | M | 58 | Lung cancer | Dmab | 2 | Mandible | 2.33 | 2.14 | -0.19 | 10.46 | 11.26 | 0.80 |
Median | 71 | 1.90 | 1.81 | -0.04 | 9.25 | 9.39 | 0.34 | |||||
Q1–Q3 | (60.3–73.0) | (1.58–2.38) | (1.54–2.40) | (-0.12–0.04) | (6.19–11.01) | (6.31–11.80) | (0.04–0.76) | |||||